Loading…
Tracing Binding Modes in Hit-to-Lead Optimization: Chameleon-Like Poses of Aspartic Protease Inhibitors
Successful lead optimization in structure‐based drug discovery depends on the correct deduction and interpretation of the underlying structure–activity relationships (SAR) to facilitate efficient decision‐making on the next candidates to be synthesized. Consequently, the question arises, how frequen...
Saved in:
Published in: | Angewandte Chemie International Edition 2015-02, Vol.54 (9), p.2849-2853 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c6176-eba68f800d760ab345951c4f1f49a04256534f281482cb049cc631b94c17fddc3 |
---|---|
cites | cdi_FETCH-LOGICAL-c6176-eba68f800d760ab345951c4f1f49a04256534f281482cb049cc631b94c17fddc3 |
container_end_page | 2853 |
container_issue | 9 |
container_start_page | 2849 |
container_title | Angewandte Chemie International Edition |
container_volume | 54 |
creator | Kuhnert, Maren Köster, Helene Bartholomäus, Ruben Park, Ah Young Shahim, Amir Heine, Andreas Steuber, Holger Klebe, Gerhard Diederich, Wibke E. |
description | Successful lead optimization in structure‐based drug discovery depends on the correct deduction and interpretation of the underlying structure–activity relationships (SAR) to facilitate efficient decision‐making on the next candidates to be synthesized. Consequently, the question arises, how frequently a binding mode (re)‐validation is required, to ensure not to be misled by invalid assumptions on the binding geometry. We present an example in which minor chemical modifications within one inhibitor series lead to surprisingly different binding modes. X‐ray structure determination of eight inhibitors derived from one core scaffold resulted in four different binding modes in the aspartic protease endothiapepsin, a well‐established surrogate for e.g. renin and β‐secretase. In addition, we suggest an empirical metrics that might serve as an indicator during lead optimization to qualify compounds as candidates for structural revalidation.
Changing poses: The optimization of lead structures relies on the systematic variation of the substituents decorating a given hit scaffold which is based on one binding pose that is supposed to be invariable. For a given core scaffold, only minor chemical variations were found to result in four different binding modes. An indicative metric is suggested to assess candidates that qualify for structural revalidation. |
doi_str_mv | 10.1002/anie.201411206 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1700975602</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1657324674</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6176-eba68f800d760ab345951c4f1f49a04256534f281482cb049cc631b94c17fddc3</originalsourceid><addsrcrecordid>eNqF0b9vEzEcBfATAtFSWBmRJRYWB3_9844tRCWNFNoKFcFm-Xy-1u2dHWxHUP56LkqJEEsne_i8J1uvql4DmQEh9L0J3s0oAQ5AiXxSHYOggJlS7Ol054xhVQs4ql7kfDv5uibyeXVEhWSESziurq-SsT5co48-dLvzc-xcRj6gM19wiXjtTIcuNsWP_rcpPoYPaHFjRje4GPDa3zl0GfOUiD2a541JxVt0mWJxJju0Cje-9SWm_LJ61pshu1cP50n19dPp1eIMry-Wq8V8ja0EJbFrjaz7mpBOSWJaxkUjwPIeet4Ywqd3C8Z7WgOvqW0Jb6yVDNqGW1B911l2Ur3b925S_LF1uejRZ-uGwQQXt1mDIqRRQhL6OJVCMcql4hN9-x-9jdsUpo_slBCkoSAnNdsrm2LOyfV6k_xo0r0Gondr6d1a-rDWFHjzULttR9cd-N95JtDswU8_uPtH6vT8fHX6bzneZ30u7tcha9Kdloopob-dLzWlwL_UfKm_sz89H62d</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1655509216</pqid></control><display><type>article</type><title>Tracing Binding Modes in Hit-to-Lead Optimization: Chameleon-Like Poses of Aspartic Protease Inhibitors</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Kuhnert, Maren ; Köster, Helene ; Bartholomäus, Ruben ; Park, Ah Young ; Shahim, Amir ; Heine, Andreas ; Steuber, Holger ; Klebe, Gerhard ; Diederich, Wibke E.</creator><creatorcontrib>Kuhnert, Maren ; Köster, Helene ; Bartholomäus, Ruben ; Park, Ah Young ; Shahim, Amir ; Heine, Andreas ; Steuber, Holger ; Klebe, Gerhard ; Diederich, Wibke E.</creatorcontrib><description>Successful lead optimization in structure‐based drug discovery depends on the correct deduction and interpretation of the underlying structure–activity relationships (SAR) to facilitate efficient decision‐making on the next candidates to be synthesized. Consequently, the question arises, how frequently a binding mode (re)‐validation is required, to ensure not to be misled by invalid assumptions on the binding geometry. We present an example in which minor chemical modifications within one inhibitor series lead to surprisingly different binding modes. X‐ray structure determination of eight inhibitors derived from one core scaffold resulted in four different binding modes in the aspartic protease endothiapepsin, a well‐established surrogate for e.g. renin and β‐secretase. In addition, we suggest an empirical metrics that might serve as an indicator during lead optimization to qualify compounds as candidates for structural revalidation.
Changing poses: The optimization of lead structures relies on the systematic variation of the substituents decorating a given hit scaffold which is based on one binding pose that is supposed to be invariable. For a given core scaffold, only minor chemical variations were found to result in four different binding modes. An indicative metric is suggested to assess candidates that qualify for structural revalidation.</description><edition>International ed. in English</edition><identifier>ISSN: 1433-7851</identifier><identifier>EISSN: 1521-3773</identifier><identifier>DOI: 10.1002/anie.201411206</identifier><identifier>PMID: 25630461</identifier><identifier>CODEN: ACIEAY</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag</publisher><subject>Aspartic Acid Endopeptidases - antagonists & inhibitors ; Aspartic Acid Endopeptidases - chemical synthesis ; Aspartic Acid Endopeptidases - chemistry ; Aspartic Acid Endopeptidases - metabolism ; Aspartic Acid Endopeptidases - pharmacology ; Binding ; Binding Sites - drug effects ; Decision making ; Decoration ; Dose-Response Relationship, Drug ; drug design ; enzyme inhibitors ; Indicators ; Inhibitors ; ligand-enzyme binding ; Models, Molecular ; Molecular Structure ; Optimization ; Protease Inhibitors - chemical synthesis ; Protease Inhibitors - chemistry ; Protease Inhibitors - pharmacology ; Scaffolds ; structure determination ; Structure-Activity Relationship ; thermal shift assay (TSA) ; Thiophenes - chemical synthesis ; Thiophenes - chemistry ; Thiophenes - pharmacology ; X-rays</subject><ispartof>Angewandte Chemie International Edition, 2015-02, Vol.54 (9), p.2849-2853</ispartof><rights>2015 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim</rights><rights>2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.</rights><rights>2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6176-eba68f800d760ab345951c4f1f49a04256534f281482cb049cc631b94c17fddc3</citedby><cites>FETCH-LOGICAL-c6176-eba68f800d760ab345951c4f1f49a04256534f281482cb049cc631b94c17fddc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25630461$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kuhnert, Maren</creatorcontrib><creatorcontrib>Köster, Helene</creatorcontrib><creatorcontrib>Bartholomäus, Ruben</creatorcontrib><creatorcontrib>Park, Ah Young</creatorcontrib><creatorcontrib>Shahim, Amir</creatorcontrib><creatorcontrib>Heine, Andreas</creatorcontrib><creatorcontrib>Steuber, Holger</creatorcontrib><creatorcontrib>Klebe, Gerhard</creatorcontrib><creatorcontrib>Diederich, Wibke E.</creatorcontrib><title>Tracing Binding Modes in Hit-to-Lead Optimization: Chameleon-Like Poses of Aspartic Protease Inhibitors</title><title>Angewandte Chemie International Edition</title><addtitle>Angew. Chem. Int. Ed</addtitle><description>Successful lead optimization in structure‐based drug discovery depends on the correct deduction and interpretation of the underlying structure–activity relationships (SAR) to facilitate efficient decision‐making on the next candidates to be synthesized. Consequently, the question arises, how frequently a binding mode (re)‐validation is required, to ensure not to be misled by invalid assumptions on the binding geometry. We present an example in which minor chemical modifications within one inhibitor series lead to surprisingly different binding modes. X‐ray structure determination of eight inhibitors derived from one core scaffold resulted in four different binding modes in the aspartic protease endothiapepsin, a well‐established surrogate for e.g. renin and β‐secretase. In addition, we suggest an empirical metrics that might serve as an indicator during lead optimization to qualify compounds as candidates for structural revalidation.
Changing poses: The optimization of lead structures relies on the systematic variation of the substituents decorating a given hit scaffold which is based on one binding pose that is supposed to be invariable. For a given core scaffold, only minor chemical variations were found to result in four different binding modes. An indicative metric is suggested to assess candidates that qualify for structural revalidation.</description><subject>Aspartic Acid Endopeptidases - antagonists & inhibitors</subject><subject>Aspartic Acid Endopeptidases - chemical synthesis</subject><subject>Aspartic Acid Endopeptidases - chemistry</subject><subject>Aspartic Acid Endopeptidases - metabolism</subject><subject>Aspartic Acid Endopeptidases - pharmacology</subject><subject>Binding</subject><subject>Binding Sites - drug effects</subject><subject>Decision making</subject><subject>Decoration</subject><subject>Dose-Response Relationship, Drug</subject><subject>drug design</subject><subject>enzyme inhibitors</subject><subject>Indicators</subject><subject>Inhibitors</subject><subject>ligand-enzyme binding</subject><subject>Models, Molecular</subject><subject>Molecular Structure</subject><subject>Optimization</subject><subject>Protease Inhibitors - chemical synthesis</subject><subject>Protease Inhibitors - chemistry</subject><subject>Protease Inhibitors - pharmacology</subject><subject>Scaffolds</subject><subject>structure determination</subject><subject>Structure-Activity Relationship</subject><subject>thermal shift assay (TSA)</subject><subject>Thiophenes - chemical synthesis</subject><subject>Thiophenes - chemistry</subject><subject>Thiophenes - pharmacology</subject><subject>X-rays</subject><issn>1433-7851</issn><issn>1521-3773</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqF0b9vEzEcBfATAtFSWBmRJRYWB3_9844tRCWNFNoKFcFm-Xy-1u2dHWxHUP56LkqJEEsne_i8J1uvql4DmQEh9L0J3s0oAQ5AiXxSHYOggJlS7Ol054xhVQs4ql7kfDv5uibyeXVEhWSESziurq-SsT5co48-dLvzc-xcRj6gM19wiXjtTIcuNsWP_rcpPoYPaHFjRje4GPDa3zl0GfOUiD2a541JxVt0mWJxJju0Cje-9SWm_LJ61pshu1cP50n19dPp1eIMry-Wq8V8ja0EJbFrjaz7mpBOSWJaxkUjwPIeet4Ywqd3C8Z7WgOvqW0Jb6yVDNqGW1B911l2Ur3b925S_LF1uejRZ-uGwQQXt1mDIqRRQhL6OJVCMcql4hN9-x-9jdsUpo_slBCkoSAnNdsrm2LOyfV6k_xo0r0Gondr6d1a-rDWFHjzULttR9cd-N95JtDswU8_uPtH6vT8fHX6bzneZ30u7tcha9Kdloopob-dLzWlwL_UfKm_sz89H62d</recordid><startdate>20150223</startdate><enddate>20150223</enddate><creator>Kuhnert, Maren</creator><creator>Köster, Helene</creator><creator>Bartholomäus, Ruben</creator><creator>Park, Ah Young</creator><creator>Shahim, Amir</creator><creator>Heine, Andreas</creator><creator>Steuber, Holger</creator><creator>Klebe, Gerhard</creator><creator>Diederich, Wibke E.</creator><general>WILEY-VCH Verlag</general><general>WILEY‐VCH Verlag</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>K9.</scope><scope>7X8</scope><scope>7SR</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope></search><sort><creationdate>20150223</creationdate><title>Tracing Binding Modes in Hit-to-Lead Optimization: Chameleon-Like Poses of Aspartic Protease Inhibitors</title><author>Kuhnert, Maren ; Köster, Helene ; Bartholomäus, Ruben ; Park, Ah Young ; Shahim, Amir ; Heine, Andreas ; Steuber, Holger ; Klebe, Gerhard ; Diederich, Wibke E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6176-eba68f800d760ab345951c4f1f49a04256534f281482cb049cc631b94c17fddc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aspartic Acid Endopeptidases - antagonists & inhibitors</topic><topic>Aspartic Acid Endopeptidases - chemical synthesis</topic><topic>Aspartic Acid Endopeptidases - chemistry</topic><topic>Aspartic Acid Endopeptidases - metabolism</topic><topic>Aspartic Acid Endopeptidases - pharmacology</topic><topic>Binding</topic><topic>Binding Sites - drug effects</topic><topic>Decision making</topic><topic>Decoration</topic><topic>Dose-Response Relationship, Drug</topic><topic>drug design</topic><topic>enzyme inhibitors</topic><topic>Indicators</topic><topic>Inhibitors</topic><topic>ligand-enzyme binding</topic><topic>Models, Molecular</topic><topic>Molecular Structure</topic><topic>Optimization</topic><topic>Protease Inhibitors - chemical synthesis</topic><topic>Protease Inhibitors - chemistry</topic><topic>Protease Inhibitors - pharmacology</topic><topic>Scaffolds</topic><topic>structure determination</topic><topic>Structure-Activity Relationship</topic><topic>thermal shift assay (TSA)</topic><topic>Thiophenes - chemical synthesis</topic><topic>Thiophenes - chemistry</topic><topic>Thiophenes - pharmacology</topic><topic>X-rays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kuhnert, Maren</creatorcontrib><creatorcontrib>Köster, Helene</creatorcontrib><creatorcontrib>Bartholomäus, Ruben</creatorcontrib><creatorcontrib>Park, Ah Young</creatorcontrib><creatorcontrib>Shahim, Amir</creatorcontrib><creatorcontrib>Heine, Andreas</creatorcontrib><creatorcontrib>Steuber, Holger</creatorcontrib><creatorcontrib>Klebe, Gerhard</creatorcontrib><creatorcontrib>Diederich, Wibke E.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Engineered Materials Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><jtitle>Angewandte Chemie International Edition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kuhnert, Maren</au><au>Köster, Helene</au><au>Bartholomäus, Ruben</au><au>Park, Ah Young</au><au>Shahim, Amir</au><au>Heine, Andreas</au><au>Steuber, Holger</au><au>Klebe, Gerhard</au><au>Diederich, Wibke E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tracing Binding Modes in Hit-to-Lead Optimization: Chameleon-Like Poses of Aspartic Protease Inhibitors</atitle><jtitle>Angewandte Chemie International Edition</jtitle><addtitle>Angew. Chem. Int. Ed</addtitle><date>2015-02-23</date><risdate>2015</risdate><volume>54</volume><issue>9</issue><spage>2849</spage><epage>2853</epage><pages>2849-2853</pages><issn>1433-7851</issn><eissn>1521-3773</eissn><coden>ACIEAY</coden><abstract>Successful lead optimization in structure‐based drug discovery depends on the correct deduction and interpretation of the underlying structure–activity relationships (SAR) to facilitate efficient decision‐making on the next candidates to be synthesized. Consequently, the question arises, how frequently a binding mode (re)‐validation is required, to ensure not to be misled by invalid assumptions on the binding geometry. We present an example in which minor chemical modifications within one inhibitor series lead to surprisingly different binding modes. X‐ray structure determination of eight inhibitors derived from one core scaffold resulted in four different binding modes in the aspartic protease endothiapepsin, a well‐established surrogate for e.g. renin and β‐secretase. In addition, we suggest an empirical metrics that might serve as an indicator during lead optimization to qualify compounds as candidates for structural revalidation.
Changing poses: The optimization of lead structures relies on the systematic variation of the substituents decorating a given hit scaffold which is based on one binding pose that is supposed to be invariable. For a given core scaffold, only minor chemical variations were found to result in four different binding modes. An indicative metric is suggested to assess candidates that qualify for structural revalidation.</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag</pub><pmid>25630461</pmid><doi>10.1002/anie.201411206</doi><tpages>5</tpages><edition>International ed. in English</edition></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1433-7851 |
ispartof | Angewandte Chemie International Edition, 2015-02, Vol.54 (9), p.2849-2853 |
issn | 1433-7851 1521-3773 |
language | eng |
recordid | cdi_proquest_miscellaneous_1700975602 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Aspartic Acid Endopeptidases - antagonists & inhibitors Aspartic Acid Endopeptidases - chemical synthesis Aspartic Acid Endopeptidases - chemistry Aspartic Acid Endopeptidases - metabolism Aspartic Acid Endopeptidases - pharmacology Binding Binding Sites - drug effects Decision making Decoration Dose-Response Relationship, Drug drug design enzyme inhibitors Indicators Inhibitors ligand-enzyme binding Models, Molecular Molecular Structure Optimization Protease Inhibitors - chemical synthesis Protease Inhibitors - chemistry Protease Inhibitors - pharmacology Scaffolds structure determination Structure-Activity Relationship thermal shift assay (TSA) Thiophenes - chemical synthesis Thiophenes - chemistry Thiophenes - pharmacology X-rays |
title | Tracing Binding Modes in Hit-to-Lead Optimization: Chameleon-Like Poses of Aspartic Protease Inhibitors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T01%3A04%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tracing%20Binding%20Modes%20in%20Hit-to-Lead%20Optimization:%20Chameleon-Like%20Poses%20of%20Aspartic%20Protease%20Inhibitors&rft.jtitle=Angewandte%20Chemie%20International%20Edition&rft.au=Kuhnert,%20Maren&rft.date=2015-02-23&rft.volume=54&rft.issue=9&rft.spage=2849&rft.epage=2853&rft.pages=2849-2853&rft.issn=1433-7851&rft.eissn=1521-3773&rft.coden=ACIEAY&rft_id=info:doi/10.1002/anie.201411206&rft_dat=%3Cproquest_cross%3E1657324674%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c6176-eba68f800d760ab345951c4f1f49a04256534f281482cb049cc631b94c17fddc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1655509216&rft_id=info:pmid/25630461&rfr_iscdi=true |